BC Advantage Funds

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 29, 2011	MSI Methylation Sciences	$18.4M Series A	Gunnar Weikert	Working Opportunity Fund
Jun 1, 2010	Aquinox Pharmaceuticals	$25.0M Series B	Ventures West	Atlas Venture, Highbury Group, Johnson & Johnson Innovation, Kurma Partners, SR One, Baker Brothers Advisors, Johnson & Johnson Innovation

Total Raised

N/A

Valuation

N/A